Clinical and pharmacokinetic study of gemcitabine (GEM) - oxaliplatin (OXA) association in metastatic or locally advanced pancreatic adenocarcinoma.

被引：0
作者：
Airoldi, M
Cattel, L
Passera, R
Micari, C
Ferrarato, E
Zanon, C
机构：
[1] Osped San Giovanni Ant Sede, Turin, Italy
[2] Univ Turin, Fac Farm, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2059
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
[21]   CLINICAL TRIAL SIMULATIONS BASED ON A META-ANALYSIS OF STUDIES IN PATIENTS WITH LOCALLY ADVANCED AND/OR METASTATIC ADENOCARCINOMA PANCREATIC CANCER RECEIVING GEMCITABINE (GEM) ALONE OR IN COMBINATION [J].
Bennetts, M. ;
Nickens, D. J. ;
Thurm, H. C. ;
Hernandez, C. J. ;
Ahadieh, S. ;
Amantea, M. A. .
VALUE IN HEALTH, 2017, 20 (09) :A416-A416
[22]   FOLFIRINOX FOR LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA. RESULTS OF AN AGEO MULTICENTRIC PROSPECTIVE STUDY [J].
Marthey, L. ;
Sa-Cunha, A. ;
Blanc, J. F. ;
Cueff, A. ;
Francois, E. ;
Trouilloud, I. ;
Malka, D. ;
Bachet, J. ;
Coriat, R. ;
Taieb, J. .
ANNALS OF ONCOLOGY, 2012, 23 :238-238
[23]   Gemcitabine plus oxaliplatin in advanced or metastatic pretreated pancreatic cancer [J].
Anghel, Rodica M. ;
Popescu, Irinel ;
Ionescu, Mihnea ;
Stanculeanu, Dana ;
Minea, Laurentia ;
Bacinschi, Xenia ;
Cringeanu, Alexandrina .
ANNALS OF ONCOLOGY, 2006, 17 :325-325
[24]   A phase I open-label dose-escalation study of AL2846 in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma. [J].
Liu, Rui ;
Deng, Ting ;
Bai, Ming ;
Zhang, Le ;
Ning, Tao ;
Wang, Xia ;
Ji, Zhi ;
Yang, Yuchong ;
Ge, Shaohua ;
Li, Hongli ;
Duan, Jingjing ;
Ba, Yi .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[25]   Clinical and molecular profiling of locally advanced compared with metastatic pancreatic adenocarcinoma [J].
Picardo, Sarah Louise ;
O'Kane, Grainne M. ;
Fischer, Sandra ;
Zhang, Amy ;
Denroche, Robert Edward ;
Jang, Gun Ho ;
Dodd, Anna ;
Grant, Robert C. ;
Grunwald, Barbara ;
Moura, Shari ;
Elimova, Elena ;
Prince, Rebecca M. ;
Zogopoulos, George ;
Notta, Faiyaz ;
Wilson, Julie ;
Gallinger, Steven ;
Knox, Jennifer J. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[26]   Retrospective trial of concurrent gemcitabine (GEM) or infusional 5-fluoruracil (5-FU), folinic acid (FA), interferon (IFN) treatment in patients with locally advanced or metastatic pancreatic adenocarcinoma. [J].
Eickhoff, AS ;
Jakobs, R ;
Riemann, JF .
GASTROENTEROLOGY, 2000, 118 (04) :A517-A517
[27]   Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma [J].
Bullock, Andrea ;
Stuart, Keith ;
Jacobus, Susanna ;
Abrams, Thomas ;
Wadlow, Raymond ;
Goldstein, Michael ;
Miksad, Rebecca .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (06) :945-+
[28]   A triple approach strategy for patients with locally advanced pancreatic adenocarcinoma. [J].
Cantore, M. ;
Girelli, R. ;
Mambrini, A. ;
Frigerio, I. ;
Boz, G. ;
Simoncini, E. ;
Lusenti, A. ;
Orlandi, M. ;
Bassi, C. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[29]   A dose-escalation study of gemcitabine (Gem) plus oxaliplatin (Ox) in combination with imatinib in patients (pts) with gemcitabine-refractory advanced pancreatic adenocarcinoma (PC) [J].
Starling, N. ;
Hawkes, E. A. ;
Chau, I. ;
Watkins, D. J. ;
Thomas, J. ;
Webb, J. ;
Brown, G. ;
Thomas, K. ;
Oates, J. R. ;
Cunningham, D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[30]   A phase I trial of chemoradiation therapy with concurrent full dose gemcitabine for unresectable locally advanced pancreatic adenocarcinoma. [J].
Ioka, T ;
Tanaka, S ;
Nakaizumi, A ;
Nishiyama, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :360S-360S
12345